Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, presenting promising progress across various clinical and industrial apps. With its structural similarity to Obviously derived human serum albumin, OsrHSA offers a safer, extra reliable option for therapeutic use, notably in drug sup